Bioenergetic consequences of PINK1 mutations in Parkinson disease
about
The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's DiseaseThe spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergeticsParkinson's disease proteins: Novel mitochondrial targets for cardioprotectionSchisandrin B as a hormetic agent for preventing age-related neurodegenerative diseasesMitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expressionMitophagy mechanisms and role in human diseasesCell biology. Metabolic control of cell deathPINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncouplingMitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cellsConcise review: Patient-derived olfactory stem cells: new models for brain diseases.The bioenergetic status relates to dopamine neuron loss in familial PD with PINK1 mutationsEarly-onset Parkinson's disease due to PINK1 p.Q456X mutation--clinical and functional studyDopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesisPINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.Loss of PINK1 impairs stress-induced autophagy and cell survivalPINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR.PINK1 deficiency enhances autophagy and mitophagy inductionAutophagy as an essential cellular antioxidant pathway in neurodegenerative disease.Store-operated Ca2+ entry controls ameloblast cell function and enamel development.Synaptic protein alterations in Parkinson's disease.The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's diseaseParkinson's disease: an update on pathogenesis and treatment.The hallmarks of Parkinson's disease.Calcium signaling in Parkinson's disease.PKA Phosphorylation of NCLX Reverses Mitochondrial Calcium Overload and Depolarization, Promoting Survival of PINK1-Deficient Dopaminergic NeuronsThe mitochondrial kinase PINK1: functions beyond mitophagy.PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease.Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.Regulation of mitochondrial permeability transition pore by PINK1.Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation.Pink1 and Parkin regulate Drosophila intestinal stem cell proliferation during stress and aging.Resveratrol Ameliorates Mitochondrial Elongation via Drp1/Parkin/PINK1 Signaling in Senescent-Like Cardiomyocytes.Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss.
P2860
Q26765894-D2EFFC40-835C-45B8-BB4C-E3DF061A873FQ26778368-B606171A-9027-4F0C-A476-128A050AC281Q26781796-509168FA-F5DA-43FE-8805-4577AB650BE3Q27002536-3CACF8A8-7491-4863-A280-C5E21FC52E7FQ28115890-F6B775C6-D694-414A-92AF-405BD6464519Q28390998-B6A4ADDA-307B-4460-8F40-1396E10AA5D7Q28397089-7260D671-FC9A-471D-9FB9-EF3F3867DE92Q28593164-F537DDE1-0E9A-4EC2-85FB-241EDED3A859Q30844792-E72E3313-B33C-4EDC-97B7-5573801598D8Q34409499-39F34996-7020-466E-AD74-353D8AC970D1Q34516419-A22CA177-649B-4242-9871-B66CBD691E95Q34617223-DFBD84E0-2245-400C-8954-BB82E0A5707AQ34919409-AAA08825-2178-4202-A2FA-199F82995FBCQ35056685-49267057-75BF-4C0E-8761-065DC5D4CF8EQ35153949-3EDE7968-1A35-4EAD-8EC9-BAA2C317E0F7Q36852642-031514D4-2349-457D-BDF2-58B3C8762BC7Q36997974-0CD269B2-F1CD-4B94-BCFA-F48E5C313AF9Q37539279-D1476D25-41F0-480E-8EF1-986C412E8DC2Q37711776-C49AA6A6-8BED-4339-8AEA-1CEEBF82B75AQ37972089-14B41A2F-1D36-405E-96C3-5110270B5438Q38016276-63D2EA7F-4589-44DC-9154-1444E9801BD7Q38099279-6EDCBE76-1968-46B7-83C1-1EDDABD99963Q38105645-21495921-1E86-4147-A45A-A82F01E6EF42Q38208179-64DA69E7-F337-4E65-A40C-AAC2CBDDC3EFQ38829987-793C70DC-59B5-47E0-8A43-D18DE8083159Q38850628-CF3E9F11-8EEB-4709-8DFA-9BAB78DF1B62Q38971958-CA662144-A591-405B-9C21-C9C8E6999708Q38993107-6B8A4923-5173-48C1-8BCB-BE94050581D0Q39199926-4A97306E-E4D1-4157-BAED-E6296DA674C3Q41786008-01016CB2-1D0C-4752-86B2-600045881C65Q42081903-DBBCC486-FF80-46AF-9768-FF2D03C0A544Q46087071-DFFA585C-F470-49F4-BCA1-68E727265D9AQ46381753-13ACAB6B-2B1E-4B27-B733-EB5FF184DC24Q55031519-C8BBEAD1-8B1B-4B0C-86CF-E7C12A3BFD5A
P2860
Bioenergetic consequences of PINK1 mutations in Parkinson disease
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@ast
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@en
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@nl
type
label
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@ast
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@en
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@nl
prefLabel
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@ast
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@en
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@nl
P2860
P50
P1433
P1476
Bioenergetic consequences of PINK1 mutations in Parkinson disease
@en
P2093
Anne Grunewald
Anthony Henry Vernon Schapira
P2860
P304
P356
10.1371/JOURNAL.PONE.0025622
P407
P577
2011-01-01T00:00:00Z